Policy considerations pose options for leaders to reduce costly disparities in diabetes
|
|
As newly elected or reelected national leaders consider paths forward for continued implementation of the Affordable Care Act, an innovative, locally-implemented program focused on reducing disparities in diabetes is releasing a new set of policy considerations to help inform decisions on national health policy.
The Alliance to Reduce Disparities in Diabetes, a national program launched and supported by The Merck Company Foundation, released “Policy Considerations That Make the Link,” that offers policymakers options for ways to advance changes to overcome the systemic and structural barriers that have blocked the ability to deliver and sustain effective diabetes care to those most in need.
“The document connects the on-the-ground experiences of the Alliance grantees with the issues facing national decision makers as they consider ways to get more value, quality, efficiency and innovation into our health care system,” Noreen Clark, PhD, Director of the Alliance’s National Program Office said.
The considerations pose a series of questions surrounding the identified need to realign financial incentives affecting health systems, providers and patients as a mechanism for reducing disparities in diabetes.
